Cargando…

Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy

Purpose. 4D-CT is routine imaging for lung cancer patients treated with stereotactic body radiotherapy. No studies have investigated optimal 4D phase selection for radiomics. We aim to determine how phase data should be used to identify prognostic biomarkers for distant failure, and test whether sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Angela, van Herk, Marcel, Faivre-Finn, Corinne, Brown, Sean, McWilliam, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOP Publishing 2021
Materias:	Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144744/ https://www.ncbi.nlm.nih.gov/pubmed/33882470 http://dx.doi.org/10.1088/1361-6560/abfa34

Ejemplares similares

Automated gross tumor volume contour generation for large‐scale analysis of early‐stage lung cancer patients planned with 4D‐CT
por: Davey, Angela, et al.
Publicado: (2020)

Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence
por: Davey, Angela, et al.
Publicado: (2023)

Radial Data Mining to Identify Density–Dose Interactions That Predict Distant Failure Following SABR
por: Davey, Angela, et al.
Publicado: (2022)

Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy
por: Johnson-Hart, Corinne, et al.
Publicado: (2020)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

Quantitative evaluation of 4D Cone beam CT scans with reduced scan time in lung cancer patients
por: Bryce-Atkinson, Abigail, et al.
Publicado: (2019)

Comparison of intensity modulated radiotherapy plan optimisation methods for a 1.5 T MR‐Linac
por: Chuter, Robert, et al.
Publicado: (2018)

Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2022)

Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
por: Oikonomou, Anastasia, et al.
Publicado: (2018)

Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy
por: Parr, Elsa, et al.
Publicado: (2020)

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023)

Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
por: McWilliam, Alan, et al.
Publicado: (2020)

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
por: Banfill, Kathryn, et al.
Publicado: (2021)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer
por: Pepin, Abigail N., et al.
Publicado: (2022)

The impact of baseline shifts towards the heart after image guidance on survival in lung SABR patients
por: Johnson-Hart, Corinne, et al.
Publicado: (2020)

MRI feature-based radiomics models to predict treatment outcome after stereotactic body radiotherapy for spinal metastases
por: Chen, Yongye, et al.
Publicado: (2023)

The evolving role of radiotherapy in non-small cell lung cancer
por: Brown, Sean, et al.
Publicado: (2019)

Prognostic Value of a CT Radiomics-Based Nomogram for the Overall Survival of Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
por: Wang, Lihong, et al.
Publicado: (2023)

CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT)
por: Al-Umairi, Rashid, et al.
Publicado: (2022)

Stereotactic body radiotherapy for organ-confined prostate cancer
por: Katz, Alan J, et al.
Publicado: (2010)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Utility of Radiomics for Predicting Patient Survival in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With Stereotactic Body Radiotherapy
por: Wu, Kui, et al.
Publicado: (2020)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Stereotactic body radiotherapy for solitary spine metastasis
por: Lee, Sunyoung, et al.
Publicado: (2013)

A Survey of Stereotactic Body Radiotherapy in Korea
por: Bae, Sun Hyun, et al.
Publicado: (2015)

Stereotactic body radiotherapy in lung cancer: an update
por: Abreu, Carlos Eduardo Cintra Vita, et al.
Publicado: (2015)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for Metastatic and Recurrent Ewing Sarcoma and Osteosarcoma
por: Brown, Lindsay C., et al.
Publicado: (2014)

Thoracic radiotherapy in small cell lung cancer—a narrative review
por: Levy, Antonin, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer
por: Kalinauskaite, Goda, et al.
Publicado: (2020)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules
por: Owen, Dawn, et al.
Publicado: (2015)

CT Imaging Findings after Stereotactic Radiotherapy for Liver Tumors
por: Brook, Olga R., et al.
Publicado: (2015)

Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
por: Levy, Antonin, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Gynecologic Cancer
por: Kubicek, Gregory J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mnfjk27vat6fumk3a2b2stgpft